Researchers and authors can use the Manuscript Formatting Template from here.
Aims and Scope
Open Access Journal of Molecular Medicine is an international peer reviewed open access journal that publishes scholarly research related to molecular mechanisms of disease, molecular diagnostics, biomedical science, and translational medical research. The journal welcomes contributions from researchers in molecular biology, genetics, clinical medicine, biomedical sciences, and related life sciences disciplines that investigate biological processes at the molecular and cellular levels.
The objective of the journal is to publish research that advances understanding of molecular pathways involved in human health and disease, including molecular signalling systems, genetic regulation, cellular communication, and biochemical mechanisms that influence disease development, diagnosis, and therapeutic intervention. The journal provides a scientific venue for experimental studies, laboratory investigations, clinical molecular research, and translational research that connects fundamental molecular discoveries with clinical practice.
The journal welcomes original research articles, review articles, systematic reviews, short communications, case reports, methodological studies, and technical reports describing experimental findings and analytical studies related to molecular medicine. Studies that improve knowledge of disease mechanisms, molecular diagnostics, targeted therapy development, and biomarker discovery are appropriate for this journal.
Molecular Biology and Cellular Mechanisms
Research addressing cellular signalling pathways, gene expression regulation, molecular interactions, cellular metabolism, protein synthesis, nucleic acid biology, RNA processing, epigenetic regulation, chromatin structure, transcriptional control, translation mechanisms, and post-translational modifications falls within the scope of this journal. Investigations exploring molecular communication between cells, intracellular signalling networks, and regulatory systems controlling cellular behaviour are also considered.
Studies examining apoptosis, autophagy, oxidative stress responses, mitochondrial function, cellular stress signalling, and immune system interactions at the molecular level are relevant topics for submission.
Genetics and Genomic Medicine
The journal publishes research related to genetic variation, gene mutations, genomic instability, gene mapping, genome sequencing, transcriptomics, and molecular genetics associated with disease development. Studies examining inherited disorders, genetic predisposition to disease, chromosomal abnormalities, and gene regulatory mechanisms in human health are appropriate for publication.
Research using genomic technologies such as next-generation sequencing, genome-wide association studies, gene expression profiling, and molecular diagnostic assays is encouraged.
Molecular Pathology and Disease Mechanisms
Studies investigating the molecular basis of diseases, including cancer, cardiovascular diseases, neurological disorders, metabolic diseases, autoimmune disorders, infectious diseases, and rare genetic conditions, are welcome. Research that identifies molecular markers associated with disease progression, therapeutic response, and prognosis is relevant to the journal.
Investigations involving molecular pathology techniques, tissue-based molecular analysis, and molecular imaging methods that improve disease characterisation and diagnosis are suitable for submission.
Translational and Clinical Molecular Research
The journal considers translational research connecting laboratory discoveries to clinical applications. Studies involving biomarker discovery, targeted therapies, personalised medicine approaches, molecular drug development, and molecular diagnostic tools are particularly relevant.
Clinical research examining molecular indicators for disease detection, treatment monitoring, and prediction of therapeutic outcomes is also appropriate. Studies exploring pharmacogenomics, molecular therapeutics, gene-based treatment strategies, and clinical molecular testing methods fall within the scope of the journal.
Biotechnology and Biomedical Technologies
Research involving molecular biotechnology, recombinant DNA technology, gene editing systems, CRISPR-based applications, protein engineering, synthetic biology, molecular biosensors, diagnostic assay development, and biomedical device innovation related to molecular analysis is also considered.
Studies addressing laboratory technologies used in molecular medicine, including polymerase chain reaction techniques, sequencing technologies, molecular imaging, proteomic analysis, metabolomic profiling, and bioinformatic analysis are suitable for publication.
Article Types
Open Access Journal of Molecular Medicine publishes original research articles, review articles, systematic reviews, experimental reports, clinical research papers, methodological studies, short communications, perspectives, technical notes, and case reports related to molecular medicine and biomedical science.
Authors are encouraged to submit manuscripts that clearly describe research objectives, experimental design, analytical methods, statistical evaluation, and interpretation of findings relevant to molecular medicine and disease research.
Topics of Interest Include, But Are Not Limited To
molecular medicine, molecular biology, cellular biology, molecular genetics, genomic medicine, gene regulation, transcription mechanisms, translation mechanisms, epigenetics, chromatin remodeling, RNA biology, microRNA research, noncoding RNA studies, protein synthesis, protein structure, protein interactions, molecular signaling pathways, cell signaling, intracellular signaling networks, apoptosis, autophagy, oxidative stress responses, mitochondrial biology, molecular metabolism, metabolic regulation, molecular immunology, immune signaling pathways, inflammatory signaling systems, cancer molecular biology, oncogenes, tumor suppressor genes, cancer genomics, tumor microenvironment studies, molecular pathology, biomarker discovery, disease biomarkers, molecular diagnostics, molecular imaging, translational medicine, personalized medicine, precision medicine, pharmacogenomics, molecular therapeutics, targeted therapy development, drug target discovery, molecular drug design, protein engineering, recombinant DNA technology, gene editing systems, CRISPR technology, genome sequencing, next generation sequencing, transcriptomics, proteomics, metabolomics, systems biology, bioinformatics analysis, computational biology, molecular epidemiology, clinical molecular research, infectious disease molecular studies, cardiovascular molecular research, neurological molecular research, metabolic disorder research, autoimmune disease molecular mechanisms, rare genetic diseases, diagnostic biomarker studies, therapeutic biomarker studies, laboratory medicine research, molecular biotechnology, biomedical device development, diagnostic assay design, molecular biosensors, and translational biomedical science.
The Open Access Journal of Molecular Medicine (OAJMM) aims to serve as a premier platform for the publication of cutting-edge research at the interface of molecular biology and medicine. Our journal covers a wide range of topics, including but not limited to:
Molecular Basis of Disease: Understanding the molecular mechanisms underlying disease pathogenesis, progression, and treatment response.
Genomic Medicine: Advancements in genomics, transcriptomics, and proteomics with implications for personalized medicine and precision healthcare.
Molecular Diagnostics: Development and validation of molecular biomarkers, diagnostic assays, and imaging techniques for disease detection and monitoring.
Therapeutic Strategies: Novel therapeutic approaches targeting molecular pathways, including small molecules, biologics, gene therapies, and nanomedicine.
Regenerative Medicine: Harnessing the power of molecular biology to develop regenerative therapies for tissue repair and regeneration.
Cancer Biology: Molecular insights into cancer biology, tumor heterogeneity, drug resistance mechanisms, and targeted therapies.
Infectious Diseases: Molecular mechanisms of infectious diseases, host-pathogen interactions, and development of antiviral and antimicrobial agents.
Translational Research: Bridging the gap between basic science discoveries and clinical applications through translational research efforts.
We welcome original research articles, reviews, clinical studies, case reports, and perspectives that contribute to advancing our understanding of molecular mechanisms in health and disease. Join us in the pursuit of scientific discovery and innovation in molecular medicine. Some of the subject areas that the journal focuses on include:
|
Molecular medicine |
Biomarkers |
Systems biology |
|
Human experimentation |
Drug development |
Cell signaling |
|
Bench to bedside |
Precision medicine |
Cell biology |
|
Bedside to bench |
Personalized medicine |
Cellular mechanisms |
|
Translational research |
Genomics |
Cellular pathways |
|
Clinical science |
Proteomics |
Molecular mechanisms of disease |
|
Basic science |
Pharmacogenomics |
Molecular pathology |
|
Molecular biology |
Bioinformatics |
Molecular virology |
|
Medicine |
Data mining |
Molecular immunology |
|
Molecular mechanisms |
Artificial intelligence |
Molecular hematology |
|
Disease pathogenesis |
Machine learning |
Molecular cardiology |
|
Precision medicine |
Targeted therapy |
Molecular neurology |
|
Personalized healthcare |
Immunotherapy |
Molecular oncology |
|
Biomarker discovery |
Therapeutic antibodies |
Molecular genetics |
|
Therapeutic interventions |
Pharmacodynamics |
Molecular therapeutics |
|
Drug development |
Pharmacokinetics |
Molecular pharmacogenomics |
|
Genetic medicine |
Drug safety |
Molecular epidemiology |
|
Pharmacology |
Drug efficacy |
Molecular biomarkers |
|
Oncology |
Drug toxicity |
Molecular diagnostics |
|
Cardiology |
Preclinical studies |
Molecular markers |
|
Neurology |
Animal models |
Molecular immunotherapy |
|
Immunology |
In vitro studies |
Molecular vaccine development |
|
Infectious diseases |
In vivo studies |
Molecular gene editing |
|
Genetics |
Drug discovery |
Molecular drug delivery |
|
Gene therapy |
High-throughput screening |
Molecular nanomedicine |
|
Regenerative medicine |
Gene editing |
Molecular targeting |
|
Diagnostic assays |
Stem cells |
Molecular mechanisms of drug resistance |
|
Imaging techniques |
Regenerative medicine |
Molecular mechanisms of therapy |
|
Molecular diagnostics |
Tissue engineering |
Molecular imaging techniques |
|
Therapeutic targets |
Drug delivery |
Molecular biology techniques |
|
Signaling pathways |
Nanotechnology |
Molecular cellular therapies |
|
Molecular pathways |
Microfluidics |
Molecular stem cell therapies |
|
Disease mechanisms |
Point-of-care testing |
Molecular tissue engineering |
|
Molecular genetics |
Companion diagnostics |
Molecular regenerative medicine |
|
Molecular profiling |
Imaging techniques |
Molecular neuroprosthetics |
|
Molecular imaging |
Magnetic resonance imaging (mri) |
Molecular precision medicine |
|
Molecular markers |
Computed tomography (ct) |
Molecular personalized medicine translational medicine |
|
Molecular targets |
Positron emission tomography (pet) |
Clinical trials |
|
Targeted therapy |
Single-photon emission computed tomography (spect) |
Health information exchange (hie) |
|
Precision oncology |
Ultrasound |
Clinical decision support systems (cdss) |
|
Molecular signatures |
Molecular imaging |
Patient-centered care |
|
Molecular epidemiology |
Optical imaging |
Patient engagement |
|
Molecular pharmacology |
Radiomics |
Health disparities |
|
Molecular therapy |
Transcriptomics |
Health outcomes |
|
Molecular analysis |
Epigenomics |
Health economics |
|
Molecular diagnostics |
Metabolomics |
Health technology assessment |
|
Molecular biomarkers |
Proteomics |
Health policy |
|
Molecular signaling |
Lipidomics |
Health informatics |
|
Molecular interactions |
Glycomics |
Clinical informatics |
|
Molecular targets |
Metagenomics |
Public health informatics |
|
Gene expression profiling |
Microbiome |
Regulatory science |
|
Genetic mutations |
Pharmacogenetics |
Drug approval process |
|
Genetic variations |
Clinical genomics |
Clinical trial design |
|
Genomic medicine |
Clinical proteomics |
Clinical trial management |
|
Genomic analysis |
Clinical metabolomics |
Pharmacovigilance |
|
Epigenetics |
Clinical lipidomics |
Adverse drug reactions |
|
Dna sequencing |
Clinical glycomics |
Drug interactions |
|
Rna sequencing |
Clinical metagenomics |
Drug repurposing |
|
Proteomics |
Digital health |
Drug repositioning |
|
Metabolomics |
Telemedicine |
Biomaterials |
|
Transcriptomics |
Electronic health records (ehrs) |
Artificial organs |
|
Health education |
Decision analysis |
Biosensors |
|
Health literacy |
Health systems research |
Wearable technology |
|
Health communication |
Health services research |
Smart sensors |
|
Health promotion, etc. |
Implementation science |
Health monitoring |

